Synthetic Biology 2020 : frontiers in risk analysis and governance / Benjamin D. Trump, Christopher L. Cummings, Jennifer Kuzma, Igor Linkov, editors.
Trump, Benjamin D.; Cummings, Christopher L.; Kuzma, Jennifer.; Linkov, Igor.
2020
TA164
Available Online

Linked e-resources

Linked Resource Online Access
Concurrent users Unlimited
Authorized users Authorized users
Document Delivery Supplied Can lend chapters, not whole ebooks

Details

Title Synthetic Biology 2020 : frontiers in risk analysis and governance / Benjamin D. Trump, Christopher L. Cummings, Jennifer Kuzma, Igor Linkov, editors.
ISBN 3030272648
9783030272647 (electronic book)
9783030272630
Publication Details Cham : Springer, 2020.
Language English
Description 1 online resource (434 pages).
Call Number TA164
Dewey Decimal Classification 660.6
Summary Synthetic biology offers powerful remedies for some of the world's most intractable problems, but these solutions are clouded by uncertainty and risk that few strategies are available to address. The incentives for continued development of this emerging technology are prodigious and obvious, and the public deserves assurances that all potential downsides are duly considered and minimized accordingly. Incorporating social science analysis within the innovation process may impose constraints, but its simultaneous support in making the end products more acceptable to society at large should be considered a worthy trade-off. Contributing authors in this volume represent diverse perspectives related to synthetic biology's social sciences, and reflect on different areas of risk analysis and governance that have developed for the field. Such perspectives include leading scholarly discussion pertaining to risk assessment, governance, ethics, and communication. The chapters of this volume note that while the first twenty years of synthetic biology development have focused strongly on technological innovation and product development, the next twenty should emphasize the synergy between developers, policymakers, and publics to generate the most beneficial, well governed, and transparent technologies and products possible. Many chapters in this volume provide new data and approaches that demonstrate the feasibility for multi-stakeholder efforts involving policymakers, regulators, industrial developers, workers, experts, and societal representatives to share responsibilities in the production of effective and acceptable governance in the face of uncertain risk probabilities. A full consideration of such perspectives may prevent a world of draconian regulations based on an insufficient or incomplete understanding of the science that underpins synthetic biology, as well as any hesitancy or fear by the public to adopt its eventual products.
Access Note Access limited to authorized users.
Source of Description Description based on print version record.
Added Author Trump, Benjamin D.
Cummings, Christopher L.
Kuzma, Jennifer.
Linkov, Igor.
Series Risk, systems and decisions (Series)
Available in Other Form Synthetic Biology 2020: Frontiers in Risk Analysis and Governance
Linked Resources Online Access
Record Appears in Online Resources > Ebooks
All Resources
Preface
Introduction to Synthetic Biology Risk Governance and Practice
Section 1: Communities of Practice
2: History of Synthetic Biology Research and Scientific Practice
3: DIY Community, Biosafety, and Codes of Conduct
4: SynBio Research Labs in the Army Corps of Engineers
Section 2: Examples of Scientific Practice
5: Research and Applications of Gene Drive Technology
6: Synthetic Biology, Digital Technologies, and Biohacking
7: Synthetic Biology experimental research
biomimicry
8: Biosafety Research for SynBio Applications in USACE Labs
Section 3: Risk Analysis Tools
9: Applications of Bayesian Networks to identify SB research needs and uncertainties
10: Societal Risk Evaluation Scheme: Early Screening and Prioritizing for Anticipatory Risk Governance
11: Synbio
decision tools to drive governance and decision making
12: Challenges of SynBio Risk Management in LCA and other fields
13: Methods for Predicting Exposures to Products and Byproducts of Synthetic Biology
14: Solution-focused risk assessment for synthetic biology applications
Section 4: Regulation and Governance
15: Comparative Analysis of Regulatory Variations for SynBio
Applications of Risk Culture
16: Adaptive & Anticipatory Governance
17: Synbio Regulatory lag and pacing problems
18: Synthetic biology governance via existing and prospective legal instruments (tentative)
Section 5: Risk Communication and Engagement
19: Risk Communication, Gene Drives, and the Zika Virus
20: Engagement with publics under uncertainty
21: Inclusion and Public Engagement in Synthetic Biology: A component of Responsible Innovation
22: Biotethical Implications of Synthetic Biology and Emerging
23: Discussion/Conclusion.

Browse Subjects

Show more subjects...

Statistics

from
to
Export